[1] Moriette G,Lescure S,Ayoubi M,et al.Apnea of prematurity:what’s new[J].Arch Pediatr,2010,17(2):186-190. [2] Schoen K,Yu T,Stockmann C,et al.Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity[J].Paediatr Drugs,2014,16(2):169-177. [3] 于梅,黄金华,朱蓉,等.枸橼酸咖啡因治疗对呼吸暂停早产儿早期肺功能的影响[J].中国当代儿科杂志,2016,18(3):206-210. [4] Picone S,Bedetta M,Paolillo P.Caffeine citrate:when and for how long.A literature review[J].J Matern Fetal Neonatal Med,2012,25(3):11-14. [5] Morton SU,Smith VC,Treatment options for apnoea of prematurity[J].Arch Dis Child Fetal Neonatal Ed,2016,101(4):352-356. [6] 林颖,林琴,钱小芳,等 .极低出生体重早产儿经不同静脉途径留置中心静脉导管的应用评价[J].中国新生儿科杂志,2013,28(1):42-44. [7] Zhao J,Gonzalez F,Mu D.Apnea of prematurity:from cause to treatment[J].Eur J Pediatr,2011,170(9):1097-1105. [8] 许景林,王瑞泉,陈冬梅.枸橼酸咖啡因与氨茶碱治疗早产儿原发性呼吸暂停的比较[J].中国当代儿科杂志,2014,16(11):1129-1132. [9] Schoen K,Yu T,Stockmann C,et al.Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity[J].Paediatr Drugs,2014,16(2):169-177. [10] Al Hazzani F.Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity[J].Clin Neonatol,2012,1(2):64-66. [11] Patel RM,Leong T,Carlton DP,et al.Early caffeine therapy and clinical outcomes in extremely preterm infants[J].J Perinatol,2013,33(2):134-140. [12] Doyle LW, Schmidt B,Anderson PJ,et al.Reduction in developmental coordination disorder with neonatal caffeine therapy[J].J Pediatr,2014,165(2):356-359. [13] Schmidt B,Roberts RS,Anderson PJ,et al.Academic performance,motor function,and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity[J].JAMA Pediatr,2017,171(6):564-572. [14] Gray PH,Flenady VJ,Charles BG,et al.Caffeine citrate for very preterm infants:effects on development,temperament and behaviour[J].J Paediatr Child Health,2011,47(4):167-172. |